Detalhe da pesquisa
1.
Advances in the ocular complications after hematopoietic stem cell transplantation.
Ann Hematol
; 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38403713
2.
miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia.
Ann Hematol
; 102(12): 3357-3367, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726492
3.
Targeting FHL1 impairs cell proliferation and differentiation of acute myeloid leukemia cells.
Biochem Cell Biol
; 100(4): 301-308, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35916339
4.
Pharmacokinetics of cefoperazone/sulbactam in critically Ill thrombotic thrombocytopenic purpura patients undergoing therapeutic plasma exchange.
J Clin Pharm Ther
; 47(8): 1232-1239, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347732
5.
Growth inhibition and suppression of the mTOR and Wnt/ß-catenin pathways in T-acute lymphoblastic leukemia by rapamycin and MYCN depletion.
Hematol Oncol
; 39(2): 222-230, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33300153
6.
Characteristics of arsenic species in cerebrospinal fluid (CSF) of acute promyelocytic leukaemia (APL) patients treated with arsenic trioxide plus mannitol.
Br J Clin Pharmacol
; 87(10): 4020-4026, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33638869
7.
Development and validation of a prediction model (AHC) for early identification of refractory thrombotic thrombocytopenic purpura using nationally representative data.
Br J Haematol
; 191(2): 269-281, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452543
8.
Influence of AS3MT polymorphisms on arsenic metabolism and liver injury in APL patients treated with arsenic trioxide.
Toxicol Appl Pharmacol
; 379: 114687, 2019 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31330140
9.
Effect of continuous venovenous haemodialysis on outcome and pharmacokinetics of arsenic species in a patient with acute promyelocytic leukaemia and acute kidney injury.
Br J Clin Pharmacol
; 85(4): 849-853, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30677159
10.
MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/ß-catenin pathway by suppressing DKK3.
J Cell Mol Med
; 22(7): 3627-3637, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29673070
11.
Long-term efficacy and safety of arsenic trioxide for first-line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia.
Cancer
; 119(1): 115-25, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22930197
12.
SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances.
Front Oncol
; 13: 1269531, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37909026
13.
Single-Center Retrospective Clinical Evaluation of Venetoclax Combined with HMAs and Half-Dose CAG for Unfit or Refractory/Relapsed AML.
Onco Targets Ther
; 16: 409-419, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334144
14.
A New Scoring System for Predicting Mortality in Hematological Malignancies with Sepsis: A Derivation and Validation Study.
Cancer Manag Res
; 15: 1073-1083, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794881
15.
The novel HLA-C*15:02:58 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual.
HLA
; 101(5): 552-553, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36478103
16.
Efficacy and safety of an HDACi- and HMA-based protocol in adults with acute myeloid leukemia of intermediate- and adverse-risk categories: a retrospective study.
Hematology
; 28(1): 2219930, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37278601
17.
Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia.
Blood
; 115(9): 1697-702, 2010 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20029047
18.
Knockdown of ADORA2A antisense RNA 1 inhibits cell proliferation and enhances imatinib sensitivity in chronic myeloid leukemia.
Bioengineered
; 13(2): 2296-2307, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35034552
19.
Loss of mismatched HLA in acute myeloid leukemia relapse after haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood: A case report.
Transpl Immunol
; 73: 101602, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429620
20.
Clinical Characteristics and Outcome Analysis for HLA Loss Patients Following Partially Mismatched Related Donor Transplantation Using HLA Chimerism for Loss of Heterozygosity Analysis by Next-Generation Sequencing.
Cell Transplant
; 31: 9636897221102902, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35670196